On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...